Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal fibrotic lung disease
characterized by profound changes in stem cell differentiation, epithelial cell phenotypes …

Myofibroblast differentiation of lung resident mesenchymal stem cells (LR-MSC) plays an
important role in idiopathic pulmonary fibrosis. By comparing the expression profiles of …

Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive
remodeling of lungs, with no known effective treatment. Although transforming growth factor …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease involving pulmonary injury
associated with tissue repair, dysfunction and fibrosis. Recent studies indicate that some …

Transdifferentiation of lung fibroblasts to myofibroblasts is a crucial pathophysiological
process in pulmonary fibrosis. MicroRNA‑375 (miR‑375) was initially identified as a tumor …

Transforming growth factor (TGF)-β1, a main profibrogenic cytokine in the progression of
idiopathic pulmonary fibrosis (IPF), induces differentiation of pulmonary fibroblasts to …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and usually lethal fibrotic lung
disease with largely unknown etiology and pathogenesis. Evidence suggests microRNAs …

Abstract Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and highly lethal
fibrotic lung disease with poor treatment and unknown etiology. Emerging evidence …

Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease with irreversible
loss of lung tissue and function. Myofibroblasts in the lung are key cellular mediators of IPF …